03:30 AM EDT, 05/14/2025 (MT Newswires) -- Seamus Mulligan, Director, on May 09, 2025, executed a purchase for 101,621 shares in Jazz Pharmaceuticals ( JAZZ ) for $9,993,082. Following the Form 4 filing with the SEC, Mulligan has control over a total of 1,277,727 ordinary shares of the company, with 1,176,106 shares held directly and 101,621 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1232524/000176558125000042/xslF345X05/edgardoc.xml